Jinxin Fertility Group Limited (FRA:3NX)

Germany flag Germany · Delayed Price · Currency is EUR
0.266
+0.004 (1.53%)
Last updated: Dec 4, 2025, 8:59 AM CET
-25.70%
Market Cap 777.25M
Revenue (ttm) 315.75M
Net Income (ttm) -112.50M
Shares Out n/a
EPS (ttm) -0.04
PE Ratio n/a
Forward PE 20.32
Dividend n/a
Ex-Dividend Date n/a
Volume 4,569
Average Volume n/a
Open 0.266
Previous Close 0.262
Day's Range 0.266 - 0.266
52-Week Range 0.252 - 0.418
Beta n/a
RSI 48.07
Earnings Date Nov 25, 2025

About Jinxin Fertility Group

Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States. It offers two treatment solutions, including artificial insemination that is performed with either husband’s sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF with intracytoplasmic sperm injection. The company also provides related services, such as nutrition guidance, Chinese medicine treatment, and psycholo... [Read more]

Industry Health Services
Founded 1951
Employees 3,198
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 3NX
Full Company Profile

Financial Performance

In 2024, Jinxin Fertility Group's revenue was 2.81 billion, an increase of 0.81% compared to the previous year's 2.79 billion. Earnings were 283.10 million, a decrease of -17.88%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.